Brandon is the Policy Coordinator for the domestic team at CEPR, where he has conducted health policy research and helped educate federal policymakers. Brandon also works on policy stakeholder outreach, administrative/logistical support, and event planning.
Prior to joining CEPR, Brandon has conducted policy, communications, and administrative work for nonprofit and political campaign organizations geared toward guaranteeing a decent standard of living. Brandon holds both a MA in political science with a concentration in American politics and an interdisciplinary BA in communications, legal institutions, economics, and government, both from American University.
All from Brandon Novick
Corporate Power Protects Medicare Advantage Fraud
A White House that claims to be cracking down on fraud should start with Medicare Advantage.
Drug Ads Are Deceptive and Deadly
Pharmaceutical companies spend billions on drug advertising — a colossal waste of money that drives up medical costs and can present serious dangers to public health.
Get Money Out of Politics
The corruption in our politics is linked to campaign contributions. An amendment to the Constitution can correct this problem.
Guarantee Health Care to All Americans
The United States can guarantee health coverage to all while reining in costs and ending the corporatization of American medicine.
New Research Reveals Millions Will Lose Medicare Advantage Coverage This Year
New research shows that giant insurers are kicking millions off Medicare Advantage this year — yet more evidence that this privatization scheme is unworkable.
Does This Trump Proposal End the Insurance Industry’s Medicare Gravy Train?
The Trump administration’s Medicare Advantage proposal was bad news for the giant insurance companies — at least for now.
Encouraging Crime: Settlement Rewards Medicare Advantage Fraud
Corporate giants use the Medicare Advantage program to steal taxpayer money – and then just pay some of the money back to settle.
The FDA Fails to Protect Americans from the Medical Device Industry
A new report sheds light on the problem of medical device safety — another policy area where corporate influence shapes outcomes.
More of the Same: Kennedy’s FDA Continues Big Pharma Corruption
Recent FDA actions under RFK Jr.’s leadership do not reflect an agency dedicated to reversing industry corruption – rather, they show one committed to continuing it.
Dueling Congressional Votes Won’t Fix the Broken US Health Care System
Partisan votes that are doomed to failure won’t fix the US health care system. If policymakers really want to lower health care costs and stop subsidizing exploitative health insurance companies, the pathway is clear: Medicare For All.
